The Silent Killer: Chagas Disease and the Ongoing Global Fight

As a child in Bolivia, Emiliana Rodríguez witnessed the sudden and tragic death of her friend during a nighttime soccer game. The cause was a disease she would come to dread—Chagas, often called the “silent killer.” Rodríguez remembers being gripped by fear, associating the nighttime with a threat that lurked unseen, only to emerge when people were most vulnerable: while they slept.

Chagas disease, often called a “monster,” is a silent and hidden threat, transmitted largely at night by blood-sucking insects. These bugs, known as triatomine bugs or “kissing bugs,” infect up to eight million people each year, and claim around 12,000 lives annually, primarily in Latin America, but with a growing presence in other continents.

Understanding Chagas Disease: The Disease, Its History, and Its Namesake

Chagas disease—also known as American trypanosomiasis—was first identified in 1909 by Brazilian physician and researcher Carlos Ribeiro Justiniano Chagas, for whom the disease is named. Over a century later, Chagas remains a significant global health problem. The World Health Organization (WHO) identifies it as a neglected tropical disease due to the lack of widespread discussion, research, and action compared to its severity and prevalence.

The primary vector, triatomine bugs, are nocturnal insects commonly found in the walls of low-income homes in rural or peri-urban areas. When they bite sleeping humans or animals, they deposit infected feces near the wound. If the feces enter the victim’s body—through scratching, touching the eyes or mouth—they can transmit the parasite Trypanosoma cruzi, which causes Chagas disease.

The Human Toll: Real Stories and Silent Suffering

After moving to Barcelona from Bolivia 27 years ago, Rodríguez thought she had left the shadows of Chagas behind. However, the silent threat would resurface in her life. Eight years ago, during her first pregnancy, medical tests revealed she was a carrier of T. cruzi. Memories of her friend’s sudden death returned, filling her with anxiety about her unborn child.

Fortunately, Rodríguez underwent preventative treatment to reduce the risk of vertical transmission—passing the infection from mother to child during pregnancy or childbirth. After her daughter’s birth, further testing confirmed the child was not infected.

A similar story unfolded in Mexico, where Elvira Idalia Hernández Cuevas only learned about Chagas after her 18-year-old daughter, Idalia, tested positive while donating blood. Like many people in affected regions, neither mother nor daughter had ever heard of the disease. Shocked and overwhelmed, they embarked on a journey to seek information and treatment, encountering a lack of awareness among local medical professionals.

Scale and Spread: Chagas Disease Around the World

Chagas disease is primarily endemic to Latin America, with an estimated 6–7 million people infected, according to the WHO. The Centers for Disease Control and Prevention (CDC) notes that about 8 million people may be affected across Mexico, Central and South America. However, because many remain asymptomatic for years, most cases go undiagnosed.

Migrations and global travel have contributed to the spread of Chagas to non-endemic regions including North America, Europe, Japan, and Australia. For example, in the United States, about 300,000 people are estimated to be living with Chagas—most are immigrants from endemic areas. The disease’s silent progression, lack of symptoms in early stages, and low public awareness result in a global case detection rate of only around 10%.

The Kissing Bug: How Chagas Is Transmitted

The triatomine bug, or “kissing bug,” earns its name from its habit of biting humans around the mouth or eyes during sleep. After feeding, the bug defecates on the skin. The infection process is unique—transmission does not occur through the bite itself, but when the parasite-laden feces enters the body through mucous membranes or broken skin. Unintentional scratching or rubbing the eyes can facilitate this process.

Although vector-borne transmission remains the most common, Chagas can also spread in other ways:

• Mother-to-child transmission during pregnancy or childbirth
• Blood transfusions and organ transplants with infected donors (declining in regions with better screening)
• Consumption of food or beverages contaminated with T. cruzi parasites (less common, but possible)

Symptoms and Complications: The Nature of ‘Silent’ Disease

Chagas is often labeled “silent” because its acute phase, usually the first weeks or months after infection, can cause only mild or non-specific symptoms such as fever, fatigue, body aches, or swelling—a scenario easily mistaken for other illnesses or ignored altogether. In many cases, the acute phase goes entirely unnoticed.

Decades later, Chagas may emerge in its chronic phase, where 20–30% of infected individuals develop serious cardiac or gastrointestinal complications. These can include arrhythmias, heart failure, enlarged esophagus (megaesophagus), or enlarged colon (megacolon). If left untreated, these complications can be fatal.

The Guardian reports that Chagas disease takes more lives annually in Latin America than any other parasitic disease, including malaria.

Diagnosis and Barriers to Treatment: A Case of Neglect

For patients like Hernández and her daughter in Mexico, finding accurate information and effective treatment presents a major challenge. A lack of awareness among both healthcare professionals and the general public can lead to misdiagnoses—a pattern seen across endemic regions. “Medical professionals don’t receive any training and mistake Chagas for other heart diseases. The majority don’t realize there is Chagas in Mexico,” Hernández explained.

The WHO classifies Chagas among neglected tropical diseases—those that predominantly affect impoverished populations and lack research funding and global policy focus. According to Colin Forsyth, a research manager at the Drugs for Neglected Diseases Initiative (DNDi), the silent nature of Chagas and the social circumstances of those impacted keep the disease hidden and under-prioritized.

Treatment: Progress and Obstacles

Chagas disease is treatable, particularly if diagnosed early. Two main medications are used: benznidazole and nifurtimox. Both drugs have been available for over 50 years and are most effective when given during the acute phase or shortly after infection. Children and newborns can often be cured, but the drugs are less effective at halting chronic complications in adults, and can cause uncomfortable side effects—from mild allergic skin reactions to dizziness and nausea, as Rodríguez herself experienced during treatment.

According to Professor David Moore, a consultant at the Hospital for Tropical Diseases in London and founder of the UK’s Chagas Hub, “Progress in eliminating Chagas is glacial,” and meeting the WHO’s 2030 targets is unlikely. There also remains little commercial incentive for pharmaceutical companies to invest in new or more effective treatments, given the socio-economic profile of most patients.

The development of new therapies and expanded access to care are urgent needs. International organizations and patient advocacy groups, such as the International Federation of Associations of People Affected by Chagas Disease (FINDECHAGAS), led by Hernández, are campaigning to bring more visibility and resources to the fight.

Raising Awareness: Global Initiatives and Advocacy

Rodríguez has become an advocate herself, participating in awareness campaigns with the Barcelona Institute for Global Health. By sharing her story, she hopes to end the silence that surrounds Chagas and encourage more people to seek testing and treatment.

The WHO established World Chagas Disease Day, observed each year on April 14 in honor of the 1909 discovery of the first human case. This annual event aims to raise global awareness and accelerate progress toward eliminating Chagas and other neglected tropical diseases as outlined in the WHO’s “Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030.”

Prevention: What You Can Do to Reduce the Risk

Preventing Chagas disease relies largely on reducing contact with triatomine bugs and improving housing conditions, especially in at-risk rural communities. The CDC recommends the following measures:

• Seal cracks and gaps around windows, walls, roofs, and doors
• Remove wood, brush, and rock piles in the vicinity of your home
• Install and maintain screens on windows and doors
• Seal openings that lead to attics, crawl spaces, or the outside
• Keep pets indoors at night and maintain clean indoor and outdoor pet areas
• Regularly inspect sleeping areas and pet resting areas for bugs

If you find a triatomine bug—don’t crush it. Instead, carefully capture it in a container, add rubbing alcohol, or freeze it in water, then take it to your local health department or university lab for identification.

The Global Outlook: Remaining Challenges and the Path Forward

Chagas disease remains a major public health challenge and a symbol of global health inequities. Scientific progress, coordinated international efforts, and increased investment in research and treatment are critical for changing the outlook. As personal stories like those of Rodríguez and Hernández become more widely known, advocates hope that broader awareness will bring renewed commitment to detection, care, and ultimately, elimination of this once-hidden monster within our homes and communities.

Sources

• World Health Organization – Chagas Disease Fact Sheet
• Centers for Disease Control and Prevention – Chagas Disease (American trypanosomiasis)
• The Guardian – The Silent Disease: Chagas Is a Killer. Now Carriers Want Their Voices Heard
• Barcelona Institute for Global Health
• FINDECHAGAS – International Federation of Associations of People Affected by Chagas Disease
• UK Chagas Hub – Hospital for Tropical Diseases

Disclaimer: This content is intended for entertainment purposes only and is not based on real events.